| Articolul precedent |
| Articolul urmator |
 |
 74 0 |
 SM ISO690:2012DIACONU, Camelia. Chronic heart failure and atrial fibrillation. In: Perspectives of the Balkan medicine in the post COVID-19 era: The 37th Balkan Medical Week. The 8th congress on urology, dialysis and kidney transplant from the Republic of Moldova “New Horizons in Urology”, Ed. 37, 7-9 iunie 2023, Chişinău. București: Balkan Medical Union, 2023, Ediția 37, p. 44. ISSN Print: ISSN 1584-9244 ISSN-L 1584-9244 Online: ISSN 2558-815X. |
| EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
| Perspectives of the Balkan medicine in the post COVID-19 era Ediția 37, 2023 |
||||||
|
Congresul "Perspectives of the Balkan medicine in the post COVID-19 era" 37, Chişinău, Moldova, 7-9 iunie 2023 | ||||||
|
||||||
| Pag. 44-44 | ||||||
|
||||||
 Descarcă PDF |
||||||
| Rezumat | ||||||
Chronic heart failure is a syndrome with high prevalence, associated with an important risk of morbidity and mortality. The prevalence of heart failure in the general population is 1-2% and increases with age. Atrial fibrillation is the most frequent sustained cardiac arrhythmia encountered in the clinical practice, with a prevalence of 2-4% in the general population. Heart failure and atrial fibrillation frequently coexist. The management of patients with these comorbidities should include identification and treatment of precipitant factors for atrial fibrillation (hyperthyroidism, uncontrolled arterial hypertension, infections, electrolytic disorders etc), treatment of heart failure, prevention of thromboembolic events, control of heart rate and rhythm. The heart failure treatment is done according to the type of heart failure: with reduced or preserved ejection fraction. Screening and treatment of cardiovascular and noncardiovascular comorbidities is recommended in all patients with heart failure. |
||||||
|
|
|
|
